CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of September 2, 2026, CGON trades at $74.47 with a market cap of $6.66B and a P/E ratio of -28.02. CGON moved -0.05% today. Year to date, CGON is +81.53%; over the trailing twelve months it is +176.26%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $91.80. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CGON insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $74.47 |
| Market Cap | $6.66B |
| P/E Ratio | -28.02 |
| EPS | $-2.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.97 |
| 52-Week Low | $14.80 |
| Volume | 159.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.23M |
| Net Income | $-224.38M |
| Gross Margin | 0.00% |
10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.80.